Categories: Financial Results

Caredose registers 425% growth in the last quarter of FY 2018-19

  • To expand its services to five more cities apart from Delhi-NCR
  • Targets expansion in South East Asia, Africa and Middle East by next year

New Delhi, April 10, 2019: A MedTech start-up company, Caredose, announced today that it has registered a growth of 425% in the last quarter of FY 2018-19, compared to the same period last year. Caredose, just an-year-old company, ensures and tracks medicine adherence from supply chain to consumption.

Speaking on the growth, Gauri Angrish, CEO, Caredose, said, “The growth and optimism that company has shown in its one-year of operation is a great motivation and reward for the team. We are addressing the big issues of medicine non-adherence, which are critical to health and well being of chronic patients. We decided to choose India for the launch as it has the largest chronic patient pool, given the sheer size of population and incidence of ailments.”

While elaborating on the company’s expansion plan, Kinshuk Kocher, COO, said, “Caredose will be expanding its foot prints to five new cities in India including Hyderabad, Mumbai, Pune, Chennai and Bangalore. We will also be looking at global expansion next year; our target countries include Indonesia, Qatar, UAE, UK, Nigeria, and South Africa, where we will be focusing on both private and public sectors.”

To our advantage is India’s highly skilled and economically viable technology development work force, which will help in reaching our goal of creating a comprehensive ecosystem for medicine adherence, he added.

There are more than 1.2 billion non-adherent patients globally and Caredose’s intent is to make a substantial dent in the number by facilitating pre-organised and labeled doses with the help of IoT dispenser for auto dispensing and tracking dose adherence in real time.

In December last year, Revised National Tuberculosis Control Program launched the ‘CAREDOSE TB Medicine Adherence Tracking Initiative’ in collaboration with Caredose at Lok Nayak Hospital, Delhi.

The company works on dual operating model where Caredose partners with healthcare providers (hospitals, pharmacies and public health organisations), and equips them with its technologies to manage their patients. Caredose also acquires patients via its website/ app and allows patients to pre-organize their medicines into dose pouches by choosing a designated partner for medicine dispensation from a list of various healthcare providers.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago